AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Enristas 1MF Tablet PR

Prescription Icon
Prescription Required

Marketer

Anthem Biopharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Enristas 1MF Tablet PR

Diabexe Duo 1MF tablets are antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. They regulate blood glucose. Administer Diabexe Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic diabetes management plan, including diet, exercise, and weight control as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals, carry a quick-acting glucose source (e.g., sugary foods or juice), and limit alcohol consumption to mitigate this risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to check blood cell counts and liver function) are necessary.

Primary Ingredients of Enristas 1MF Tablet PR

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Enristas 1MF Tablet PR

Managing type 2 diabetes

Major Benefits of Enristas 1MF Tablet PR:

Follow your doctor's instructions or refer to the product label for guidance. Consume Enristas 1MF Tablet PR with a meal.

Common Side effects of Enristas 1MF Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Enristas 1MF Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidelines. Administer Enristas 1MF Tablet PR with a meal.

How Enristas 1MF Tablet PR works:

Enristas 1MF tablets combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates pancreatic insulin release, reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Enristas 1MF Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Enristas 1MF Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Enristas 1MF Tablet PR are incompatible; the medication poses a potential risk of infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Enristas 1MF Tablet PR cautiously, potentially requiring dose modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Enristas 1MF Tablet PR cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low Enristas 1MF Tablet PR dose is typical; however, it's contraindicated in severe cases.

What if you forget to take Enristas 1MF Tablet PR :

Should you forget a dose of Enristas 1MF Tablet PR, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Enristas 1MF Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Enristas 1MF Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Enristas 1MF Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older individuals, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Enristas 1MF Tablet PR and seek immediate medical attention.
Enristas 1MF Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Enristas 1MF Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Enristas 1MF Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Enristas 1MF Tablet PR can indeed lower blood sugar (cause hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other diabetes medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Enristas 1MF Tablet PR and alcohol is unsafe. Alcohol may exacerbate the medication's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Enristas 1MF Tablet PR
56
MRP 65
13% off